• Sign in

  • Join for free
  • Donate Today!
  • We are Social
    • Facebook
    • Twitter
    • Instagram
    • YouTube
    • LinkedIn
  • Who
    we are
    • Who we are
    • Our Story
    • Rosie
    • Rosie’s Blog
    • Our Trustees
    • Our Patrons
  • What
    we do
  • Secondary
    Breast Cancer
    • What is secondary breast cancer?
    • Symptoms
    • What is the current treatment
    • Maximising quality of life
    • Your Stories
    • Where to go for information
  • Get
    involved
    • Our Fundraisers
    • How to fundraise
    • Events
      • Fonthill Open Garden Party
      • Past Events
  • News
    • News
    • In the media
    • Video
    • Rosie’s Blog
  • Contact
Secondary1st
  • Donate Today!

Search

Login

Register
  • 020 8905 3955info@secondary1st.org.uk
0
Secondary1st
  • Menu
  • Who
    we are
    • Who we are
    • Our Story
    • Rosie
    • Rosie’s Blog
    • Our Trustees
    • Our Patrons
  • What
    we do
  • Secondary
    Breast Cancer
    • What is secondary breast cancer?
    • Symptoms
    • What is the current treatment
    • Maximising quality of life
    • Your Stories
    • Where to go for information
  • Get
    involved
    • Our Fundraisers
    • How to fundraise
    • Volunteer
    • Events
      • Fonthill Open Garden Party
      • Past Events
  • News & Media
    • News
    • In the media
    • Video
    • Rosie’s Blog
  • Contact
  • Donate Today!
16February

A New Test

Next
Previous
February 16, 2022
By cuco_admin_sec
0 Comment

Scientists are working on a ground-breaking test to spot or predict a woman’s risk of developing breast cancer or three other gynaecological cancers (ovarian, cervical and uterine cancer) from one sample taken from a routine cervical smear test.  Two papers published in the journal “Nature Communications” reported on two studies that found that this test, known as the WID or women’s cancer risk identification test, is more accurate than current genetic tests and may help scientists to spot these cancers at an early stage or predict the likelihood that they may develop.

 

The WID test looks for specific markers on the DNA of cervical cells that are linked to the development of cancer.  In one of the studies, researchers analysed changes in cervical cell samples and were able to identify women with breast cancer on the basis of a unique epigenetic signature.  Further research is needed to refine the use of this test as a screening tool for the earlier detection of these four gynaecological cancers.

Categories: News
  • Search

  • Sign up for Newsletter

    * = required field
  • Categories

    • Event
    • Fundraising
    • In the media
    • News
    • Past Events
    • Rosie's blog
    • Uncategorised
    • Your Stories
  • Latest News

    • Carol goes Ziplining at Eighty

      May 09, 2022

    • Lucy, Lara, Anoushka, Alexander, Theo, Elica and Emily Go Cycling

      May 09, 2022

    • All-Day Fundraiser

      May 09, 2022

    • Lyndell Does It Again

      May 09, 2022

  • Who We Are

    • Who we are
    • Our Story
    • Rosie
    • Rosie’s blog
    • Our Trustees
    • Our Patrons
  • What We Do

    • What we do
  • Secondary Breast Cancer

    • What is secondary breast cancer?
    • Symptoms
    • What is the current treatment
    • Maximising quality of life
    • Where to go for information
  • Get Involved

    • How to fundraise
    • Our Fundraisers

© 2016 - 2022 Secondary First is a Company Limited by Guarantee. Registered in England and Wales No. 9920657. Registered Office: 1st Floor Healthaid House, Marlborough Hill, Harrow, HA1 1UD. It is a Registered Charity Number 1165614.
Site maintained by CuCo Creative.

  • Cookie Policy
  • Privacy Policy